Investing.com - Financial Markets Worldwide

Seven African countries to start testing for COVID-19 antibodies

Published 13/08/2020, 13:14
Seven African countries to start testing for COVID-19 antibodies

By Giulia Paravicini
ADDIS ABABA, Aug 13 (Reuters) - Seven African countries will
start administering coronavirus antibody tests from next week, a
regional body said on Thursday, as part of efforts to understand
the extent of the outbreak on the continent.
"Liberia, Sierra Leone, Zambia, Zimbabwe, Cameroon, Nigeria,
Morocco are the first set of countries that committed to it,"
said John Nkengasong, head of the Africa Centres for Disease
Control and Prevention, based in Addis Ababa.
Western governments are using antibody tests to find out how
many of their citizens have been infected, in the hope that will
help them reopen their economies.
Africa has so far conducted 9.4 million coronavirus tests, a
10% increase over last week, Nkengasong said. These tests show
whether people currently have COVID-19.
The continent's relative isolation has so far spared it the
worst of the pandemic, but low levels of testing in many
countries mean Africa's infection rates are likely to be higher
than reported, experts say.
As of Thursday, Africa had recorded more than a 1 million
cases of COVID-19 and 24,113 deaths, according to a Reuters
tally.
Nkengasong said 25 African countries still have full border
closures while 23 are imposing testing at entry points.
He stressed the need to harmonize border testing and
recognition of certificates in order to facilitate travel.


Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.